- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05170854
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
Study Overview
Status
Conditions
Detailed Description
There have been a select few studies addressing the effects of cirrhosis on trauma patients. These studies show an increase in morbidity and mortality. However, there is limitation in the depth and breadth of analysis. The primary aim of this study is to determine the mortality rates in cirrhotic trauma patients with a secondary end-point being the determination of the incidence of infections associated with these patients.
Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious complications in these patients. PI hypothesizes that trauma patients with cirrhosis will have higher rates of mortality and infectious complications.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Methodist Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Cirrhotic trauma patients in the United States within 2010-2018
- Patients ≥ 18 years old
Exclusion Criteria:
- Patients less than 18 years old
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 2010-2018
|
Patient death
|
2010-2018
|
Incidence of infectious complications
Time Frame: 2010-2018
|
Incidents of complications with infections
|
2010-2018
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient demographics
Time Frame: 2010-2018
|
demographics of patients
|
2010-2018
|
vital signs; clinical measurements
Time Frame: 2010-2018
|
clinical measurements
|
2010-2018
|
vital signs; pulse rate
Time Frame: 2010-2018
|
pulse rate (bpm)
|
2010-2018
|
vital signs; temperature
Time Frame: 2010-2018
|
temperature
|
2010-2018
|
vital signs; respiration rate
Time Frame: 2010-2018
|
respiration rate
|
2010-2018
|
vital signs; blood pressure
Time Frame: 2010-2018
|
blood pressure
|
2010-2018
|
injury characteristics
Time Frame: 2010-2018
|
characteristics of injuries
|
2010-2018
|
hospital and ICU lengths of stay
Time Frame: 2010-2018
|
length of days patients stays in hospital/ICU
|
2010-2018
|
transfusion data
Time Frame: 2010-2018
|
data regarding transfusions
|
2010-2018
|
alcohol use indicator
Time Frame: 2010-2018
|
indicator of alcohol use
|
2010-2018
|
drug use indicator
Time Frame: 2010-2018
|
indicator of drug use
|
2010-2018
|
ventilator days
Time Frame: 2010-2018
|
days on ventilator
|
2010-2018
|
Abbreviated Injury Scale
Time Frame: 2010-2018
|
abbreviated injury scale score
|
2010-2018
|
Glasgow Coma Scale
Time Frame: 2010-2018
|
glasgow coma scale score
|
2010-2018
|
Injury Severity Score
Time Frame: 2010-2018
|
score of injury
|
2010-2018
|
discharge date
Time Frame: 2010-2018
|
date of discharge
|
2010-2018
|
arrival date
Time Frame: 2010-2018
|
date of arrival
|
2010-2018
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Parvez Mantry, MD, Methodist Dallas Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 042.HEP.2018.D
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cirrhosis
-
Postgraduate Institute of Medical Education and...Society for the Study of Liver Diseases, Chandigarh ( India )UnknownDecompensated Cirrhosis of LiverIndia
-
University Health Network, TorontoUnknown
-
National Institute of Diabetes and Digestive and...National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaboratorsRecruitingCirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing CholangitisUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingPrimary Biliary CirrhosisChina
-
RenJi HospitalNot yet recruiting
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Institute of Liver and Biliary Sciences, IndiaRecruiting
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
The Cleveland ClinicRecruiting
-
Beijing 302 HospitalLanZhou University; Chinese PLA General Hospital; Renmin Hospital of Wuhan University and other collaboratorsRecruitingDecompensated CirrhosisChina